← FDA DRUG APPROVALS

FDA ANDA · ANDA088726

CHLORPROPAMIDE

Sponsor: RISING

APPLICATION
ANDA088726
TYPE
ANDA
ORIGINAL APPROVAL
1984-08-31
LATEST ACTION
1994-12-30
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLORPROPAMIDEDiscontinued
CHLORPROPAMIDE 250MG · TABLET · ORAL

Approval history

1994-12-30Manufacturing (CMC) · Supplement 15AP
1988-01-27Labeling · Supplement 13AP
1986-08-08Manufacturing (CMC) · Supplement 7AP
1986-08-08Manufacturing (CMC) · Supplement 5AP
1986-08-08Manufacturing (CMC) · Supplement 6AP
1986-03-13Manufacturing (CMC) · Supplement 4AP
1985-09-24Manufacturing (CMC) · Supplement 2AP
1984-08-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →